e-mail: [email protected] This article was submitted to Frontiers in Plant Metabolism and Chemodiversity, a specialty of Frontiers in Plant Science
tirzepatide [7, 37, 41, 46, 48, 50]
These medicines often cause significant appetite suppression and early satiety, leading to substantially reduced food consumptionthe intended therapeutic effect for weight management
This modulation potentially alters how IGFs engage with diverse bodily tissues
10.1038/cddis.2017.28 Summary Keywords GLP-1, oral delivery, vagal afferents, diabetes, obesity, peptide Citation New RRC, Bogus M, Travers GN, Hahn U, Vaiceliunaite A, Burnet M, Wang JH and Wen H (2024) Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
doi: 10.1101/2025.01.27.634587 102 SongX-HDingY-HChenJ-S